Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion type Assertion NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_head.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion description "[SPRY1 expression was also found to be significantly up-regulated in the cases without underlying cirrhosis compared with those with cirrhosis (log fold change of 0.35 and -0.02, respectively, P?<?0.05), whereas SPRY2 expression was significantly lower in the cases with advanced HCC (log fold change of -0.12 and -0.52 in early and advanced stages, respectively, P?<?0.05) and in those with angiolymphatic invasion (log fold change of -0.47 and -0.16 in the presence and absence thereof, P?<?0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_provenance.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion evidence source_evidence_literature NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_provenance.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion SIO_000772 21932411 NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_provenance.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion wasDerivedFrom befree-2016 NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_provenance.
- NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_assertion wasGeneratedBy ECO_0000203 NP925023.RAC_4W2MRulD9Re7VIS91IafT4aGmVcYJusIuK4x5O26c130_provenance.